1. Home
  2. SJM vs SRPT Comparison

SJM vs SRPT Comparison

Compare SJM & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SJM
    SELLHOLDBUYas of 3 hours ago
  • SRPT
    SELLHOLDBUYas of 3 hours ago
  • Stock Information
  • Founded
  • SJM 1897
  • SRPT 1980
  • Country
  • SJM United States
  • SRPT United States
  • Employees
  • SJM N/A
  • SRPT N/A
  • Industry
  • SJM Packaged Foods
  • SRPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SJM Consumer Staples
  • SRPT Health Care
  • Exchange
  • SJM Nasdaq
  • SRPT Nasdaq
  • Market Cap
  • SJM 11.9B
  • SRPT 9.8B
  • IPO Year
  • SJM N/A
  • SRPT 1997
  • Fundamental
  • Price
  • SJM $118.58
  • SRPT $64.07
  • Analyst Decision
  • SJM Buy
  • SRPT Buy
  • Analyst Count
  • SJM 9
  • SRPT 21
  • Target Price
  • SJM $125.67
  • SRPT $160.52
  • AVG Volume (30 Days)
  • SJM 1.4M
  • SRPT 2.3M
  • Earning Date
  • SJM 02-27-2025
  • SRPT 04-30-2025
  • Dividend Yield
  • SJM 3.64%
  • SRPT N/A
  • EPS Growth
  • SJM N/A
  • SRPT N/A
  • EPS
  • SJM N/A
  • SRPT 2.34
  • Revenue
  • SJM $8,788,000,000.00
  • SRPT $1,901,979,000.00
  • Revenue This Year
  • SJM $8.27
  • SRPT $69.30
  • Revenue Next Year
  • SJM $1.92
  • SRPT $22.64
  • P/E Ratio
  • SJM N/A
  • SRPT $27.29
  • Revenue Growth
  • SJM 7.07
  • SRPT 52.97
  • 52 Week Low
  • SJM $98.77
  • SRPT $62.50
  • 52 Week High
  • SJM $125.75
  • SRPT $173.25
  • Technical
  • Relative Strength Index (RSI)
  • SJM 66.59
  • SRPT 26.52
  • Support Level
  • SJM $109.05
  • SRPT $62.50
  • Resistance Level
  • SJM $119.80
  • SRPT $76.67
  • Average True Range (ATR)
  • SJM 2.26
  • SRPT 4.17
  • MACD
  • SJM 0.58
  • SRPT -1.47
  • Stochastic Oscillator
  • SJM 87.48
  • SRPT 7.53

Stock Price Comparison Chart: SJM vs SRPT

SJM
SRPT
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April020406080100120140160180SJM VS SRPT

About SJM The J.M. Smucker Company

J.M. Smucker is a packaged food company that primarily sells through the US retail channel (78% of fiscal 2024 revenue came through its retail pet foods, coffee, and frozen handheld/spreads segments), with the remaining share consisting of Hostess and international (primarily Canada). Retail coffee is its largest category (33% of sales) with brands Folgers and Dunkin'. Pet foods (22% of sales) holds leading brands like Milk-Bone and Meow Mix. Of its remaining, approximately 22% comes from consumer foods, primarily peanut butter and jelly, through brands Jif and Smucker's. The company acquired Hostess Brands in fiscal 2024 to boost its snack and convenience store presence.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use